Improved Outcome after 'Bottom-Up' Immunosuppression in Liver Transplant Recipients with Preoperative Renal Impairment

Schnitzbauer, Andreas A. and Doenecke, Axel and Sothmann, Johannes L. and Loss, Martin and Farkas, Stefan A. and Hartl, Janine and Tsui, Tung-Yu and Baier, Lucia and Kirchner, Gabriele and Obed, Aiman and Bein, Thomas and Geissler, Edward K. and Scherer, Marcus N. and Schlitt, Hans J. (2010) Improved Outcome after 'Bottom-Up' Immunosuppression in Liver Transplant Recipients with Preoperative Renal Impairment. EUROPEAN SURGICAL RESEARCH, 45 (3-4). pp. 356-367. ISSN 0014-312X,

Full text not available from this repository. (Request a copy)

Abstract

Background: Most patients with high MELD scores have impaired renal function prior to transplantation. Patient and Methods: A retrospective case control study was conducted with initial low immunosuppression, which was increased when patients rejected or were clinically stable beyond day 30 ('bottom-up'). Results: Thirty patients with impaired renal function were included. Fifteen were treated with de novo cyclosporine A (CsA; group A), and 15 had 'bottom-up' immunosuppression (group B). Baseline renal function was similar: serum creatinine (SCr) median 1.8 mg/dl (range: 1.5-4.0 mg/dl; group A) versus 2.4 mg/dl (range: 1.5-4.0 mg/dl; group B; p = 0.24). The requirement for renal replacement therapy was significantly lower in group B (p = 0.032). Ten received 'bottom-up' immunosuppression [4 CsA/1 sirolimus (Sir) 'on demand' after rejection, 5 Sir (stable)] beyond day 30. By months 6 and 12 (1.6 mg/dl vs. 1.2 mg/dl), SCr values were significantly better in group B (p = 0.006). Renal function in group B did not differ between patients receiving CsA or Sir. Overall complication rates, survival and biopsy-proven acute rejection were similar, although BANFF scores were higher in group B (p = 0.004). Conclusion: Successful implementation of 'bottom-up' immunosuppression in liver transplant recipients with high lab-MELD scores and renal dysfunction at the time of transplantation has the potential to substantially improve short- and long-term outcomes. Copyright (C) 2010 S. Karger AG, Basel

Item Type: Article
Uncontrolled Keywords: DOSE CALCINEURIN INHIBITOR; COMBINED MYCOPHENOLATE-MOFETIL; SOLID-ORGAN TRANSPLANTATION; RISK-FACTORS; INFECTIOUS COMPLICATIONS; INDUCTION-THERAPY; CLINICAL-TRIAL; DYSFUNCTION; FAILURE; CONVERSION; Clinical immunosuppression; Cyclosporine A; 'Bottom-up' immunosuppression; Renal impairment; Liver transplantation; mTOR inhibitor
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 17 Aug 2020 06:56
Last Modified: 17 Aug 2020 06:56
URI: https://pred.uni-regensburg.de/id/eprint/25450

Actions (login required)

View Item View Item